Bucking trends.
Backed by experience.
We’re developing therapies to reverse the debilitating consequences of damage and disease of the brain and spinal cord to restore independence and improve lives.
Leadership
-

Travis Stiles, PhD
CEO & Co-founder
-

David Weiner, MD
Executive Chairman
-

William Hoekstra, PhD
Drug Discovery & Development
-

Lynne Mayman, MS, PMP
Project Management
-

Sarah Busch, PhD
Non-Clinical Translation
-

Ryan McMillian, MBA
CFO & Financial Strategy
-

Shawn Gahr, MIA
COO & Co-founder
Scientific Advisory Board
-

Lawrence Goldstein, PhD
-

Jennifer Rauch, PhD
-

Kurt Brunden, PhD
-

Jeff Goldberg, MD, PhD
-

James Whisstock, PhD
-

Rivka Kreitman, PhD
-

Miguel de los Rios, PhD
Spinal Cord Injury Advisory Council
-

Michael G. Fehlings, MD, PhD
-

Linda Jones, PT, PhD
-

Bryn Martin, PhD
-

Robert Eastlack, MD
Board of Directors
-

Travis Stiles, PhD
Chairman of the Board
-

David Weiner, MD
Board Director
-

Mike Goguen
Board Director
-

Shawn Gahr
Board Director